Hawaii Administrative Rules
Title 17 - DEPARTMENT OF HUMAN SERVICES
Department of Human Services
Chapter 1737 - SCOPE AND CONTENTS OF THE FEE FOR SERVICE MEDICAL ASSISTANCE PROGRAM
Subchapter 8 - TISSUE AND ORGAN TRANSPLANTATION
Section 17-1737-93 - Allogenic bone marrow transplant
Universal Citation: HI Admin Rules 17-1737-93
Current through February, 2024
(a) Indications for allogenic bone marrow transplant include:
(1)
Severe aplastic anemia unresponsive to usual therapy;
(2) Acute myelogenous leukemia in first
remission;
(3) Acute lymphocytic
leukemia in second remission; and
(4) Chronic leukemia after first
year.
(b) Conditions and limitations affecting allogenic bone marrow transplant include:
(1) Human leukocyte group A (HLA)
histocompatible donor shall be available;
(2) Patient has no other major systemic
disease which would result in poor potential for recovery (such as a heart
condition, liver disease, kidney damage, brain lesions, cancer in other organs
or lung disease);
(3) Patient shall
have been properly evaluated by a qualified authority in Hawaii and bone marrow
transplant is recommended as a possible curative procedure or if palliative,
with reasonable likelihood for prolongation of life and return to an active
life;
(4) No active infection at
the time of the procedure;
(5) No
general medical contraindication for the procedure and anesthesia;
(6) Informed consent shall be obtained from
the patient or the patient's representative; and
(7) Age restricted to fifty or under except
when identical twin is histocompatible and then age limit may be
fifty-five.
Disclaimer: These regulations may not be the most recent version. Hawaii may have more current or accurate information. We make no warranties or guarantees about the accuracy, completeness, or adequacy of the information contained on this site or the information linked to on the state site. Please check official sources.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.